[The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
D000410:Alanine Transaminase / Q000097:blood; D000438:Alcohols; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D005419:Flavonoids / Q000008:administration & dosage / Q000627:therapeutic use*; D005688:Galactosamine / Q000506:poisoning; D005969:Glutamate Dehydrogenase / Q000097:blood; D007274:Injections, Intraperitoneal; D008099:Liver / Q000201:enzymology; D008297:Male; D051381:Rats
D000438:Alcohols; D005419:Flavonoids; D005688:Galactosamine; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Die antihepatotoxische Wirkung von parenteral verabreichtem Silymarin bei der Galaktosamin-Hepatitis der Ratte.